Torrent Pharmaceuticals Ltd Share Price

Overview

Torrent Pharmaceuticals Ltd share price is currently ₹4,808.74, down by - ₹7.40 (0.15%) from its previous closing price of ₹4,816.14. The share price has declined -1.64% over the past month and gained 33.7% over the past year. The stock's 52-week low and high are ₹3,421.26 and ₹5,146.45, respectively. Torrent Pharmaceuticals Ltd has a market capitalisation of ₹ 1,90,000.00 Cr. The share price was last updated on 24 Aug 2026, 03:54 PM IST.

Torrent Pharmaceuticals Ltd

TORNTPHARM

₹0.00

- ₹7.40

0.15%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:54:16 pm IST

Market Data

Open Price

₹4,804.83

Prev. Close

₹4,816.14

₹4,795.98

Day Low

₹4,842.87

Day High

₹3,421.26

52 Week Low

₹5,146.45

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryLarge Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

74.62

Sector PE

42.03

PB Ratio

19.40

Sector PB

5.82

EPS

64.44

Dividend Yield

0.90

Today's Volume

159.216 K

5 Day Avg. Volume

293.444 K

PEG Ratio

5.66

Market Cap.

₹ 1,90,000.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 180% at ₹9/Share	29-May-2026	29-May-2026
DividendsInterim Dividend of 580% at ₹29/Share	18-Feb-2026	19-Feb-2026
DividendsFinal Dividend of 120% at ₹6/Share	20-Jun-2025	20-Jun-2025
DividendsInterim Dividend of 520% at ₹26/Share	31-Jan-2025	01-Feb-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
HDFC Large Cap Fund - Growth	31.81 Lac	31.81 Lac no change
Kotak Midcap Fund - Regular Plan - Growth	-	18.68 Lac (100%)
Axis Small Cap Fund - Regular Plan - Growth	-	15.22 Lac (100%)
Axis Large Cap Fund - Regular Plan - Growth	7.03 Lac	7.83 Lac (11.41%)
Axis ELSS Tax Saver Fund - Regular Plan - Growth	2.80 Lac	7.23 Lac (158.43%)

Show all holdings

About Torrent Pharmaceuticals Ltd 👋

Torrent Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in research, development, manufacturing, marketing and distribution of branded and generic pharmaceutical formulations in India and internationally. The Company focuses on various therapeutic segments, such as cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI), women healthcare (WHC), Vitamins Minerals & Nutrients (VMN) and Cosmo-Dermatology. The Company also has significant presence in diabetology, pain management, gynecology, oncology and anti-infective segments. Its brands include Ahaglow, Shelcal, Tedibar, and Unienzyme. Its tedibar brands include Tedibar bathing bar, Tedibar Atogla, Tedibar Spoo and Tedibar B4 Nappi. Its Shelcal includes Shelcal 500, Shelcal Pro Gummies, Kids Gummies, and Shelcal Total. The Company's manufacturing facilities are located in the states of Gujarat, Himachal Pradesh, Madhya Pradesh, Andhra Pradesh and Sikkim.